Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-02-07FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., authorizing changes to the product under an ex…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Efficacy Study on the Lipid-lowering Effect of Plant Sterols and Fish Oil [NA]
The update reports results from a clinical study evaluating the lipid-lowering effects of plant sterols and fish oil in individuals who are …
-
FDA approval · 2012-01-17FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries Inc.)
FDA approved a supplemental application for atorvastatin calcium from Sun Pharmaceutical Industries Inc., enabling the generic atorvastatin …
-
CLINICAL_TRIALS trial_result · 2012-01-12Clinical Trial Update: Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals
This completed clinical trial from UCLA investigates the genetic basis of familial combined hyperlipidemia in Mexican individuals. It provid…
-
CLINICAL_TRIALS research · 2012-01-12Clinical Trial Update: Community Pharmacy Assisting in Total Cardiovascular Health [NA]
An update on a University of Saskatchewan trial examining the role of community pharmacists in improving adherence to statin therapy to enha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-01-11FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare, Inc.'s supplemental application for simvastatin (ANDA 078155).
-
FDA approval · 2012-01-09FDA Approved: SIMVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for simvastatin from Lupin Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy [Phase 4]
Phase 4 clinical trial evaluating colesevelam for impaired fasting glucose in patients on niacin therapy for dyslipidemia; the study has com…
-
FDA approval · 2012-01-03FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2012-01-03FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc., indicating a labeling or…
-
CLINICAL_TRIALS trial_result · 2011-12-22Clinical Trial Update: Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM) [Phase 2]
Phase 2 trial comparing PPD10558 with atorvastatin in statin-intolerant patients due to statin-associated myalgia, focusing on safety and to…
-
CLINICAL_TRIALS trial_result · 2011-12-02Clinical Trial Update: Effects of Omega-3 Fatty Acids on the Human Gene Expression [Phase 4]
A Phase 4 clinical trial evaluated the effects of omega-3 fatty acids on human gene expression in individuals with hyperlipidemia and in hea…
-
FDA approval · 2011-12-01FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) by Organon LLC, updating its labeling and indications.
-
FDA approval · 2011-11-30FDA Approved: ATORVASTATIN CALCIUM — Original Application (Sun Pharmaceutical Industries Inc.)
FDA approved Sun Pharmaceutical Industries Inc.'s atorvastatin calcium as an original Abbreviated New Drug Application (ANDA) generic produc…
-
CLINICAL_TRIALS trial_result · 2011-11-18Clinical Trial Update: The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes [NA]
This clinical trial update reports on the triglyceride-lowering effect observed when adding docosahexaenoic acid (DHA) to statin therapy in …
-
FDA approval · 2011-11-04FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA has approved a supplemental application for simvastatin submitted by Accord Healthcare, Inc., updating the approved product information …
-
CLINICAL_TRIALS research · 2011-10-28Clinical Trial Update: Assessment of the Efficacy of Plant Stanol Esters in Reducing Cholesterol, Medellin 2011 [NA]
A Medellin 2011 clinical trial assessing the efficacy of plant stanol esters in reducing cholesterol. The sponsor is Jose María Maya Mejía a…
-
FDA approval · 2011-10-06FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for ZOCOR (simvastatin) filed by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2011-10-05Clinical Trial Update: Cholesterol and Pharmacogenetic Study [Phase 4]
A Phase 4 pharmacogenetic study on cholesterol management completed, conducted by UCSF Benioff Children's Hospital Oakland.
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: Body Worlds 3 Nutrition Display [NA]
Completed clinical trial update for a nutrition display study addressing obesity and hyperlipidemia, sponsored by Oregon Health and Science …
-
FDA approval · 2011-09-27FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Pravastatin Sodium by Aurobindo Pharma Limited.
-
FDA approval · 2011-09-16FDA Approved: SIMVASTATIN — Original Application (Micro Labs Limited)
FDA approves Micro Labs Limited's original ANDA for simvastatin, a generic statin, enabling broader generic access in the U.S.
-
CLINICAL_TRIALS trial_result · 2011-08-11Clinical Trial Update: Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia [Phase 4]
A Phase 4 trial in Korean patients with combined hyperlipidemia assessed the tolerability and lipid-lowering efficacy of a rosuvastatin‑feno…
-
CLINICAL_TRIALS research · 2011-08-02Clinical Trial Update: Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients [Phase 4]
A Phase 4 clinical trial comparing coadministration of ezetimibe with fenofibrate versus pravastatin monotherapy for hyperlipidemia in HIV-i…
-
FDA approval · 2011-07-26FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC.